Last reviewed · How we verify
NCT05803252
Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children
NA trial testing Focused Acceptance and Commitment Therapy in Neurodevelopmental Disorders in 104 participants. Completed in 28 February 2026.
30 December 2025
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 104 |
| Start date | 15 March 2023 |
| Primary completion | 30 December 2025 |
| Estimated completion | 28 February 2026 |
| Sites | 5 locations across Hong Kong |
Drugs / interventions tested
- Focused Acceptance and Commitment Therapy
- Waitlist Control
Conditions studied
- Neurodevelopmental Disorders — all drugs for Neurodevelopmental Disorders →
- Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- Development Delay — all drugs for Development Delay →
Sponsor
Chinese University of Hong Kong
Who can join
21 and older, any sex, with Neurodevelopmental Disorders or Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the proposed non-randomized waitlist-controlled design study is to evaluate the feasibility, acceptability, and potential effectiveness of using a Videoconferencing-based Individual Focused Acceptance and Commitment Therapy (FACT) approach to enhance the mental well-being of parents of children with special healthcare needs (SHCN) over a three-month period after the intervention has taken place.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05803252
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Focused Acceptance and Commitment Therapy
Trials testing the same drug.
- NCT07341425 — Focused Acceptance and Commitment Therapy (FACT) for Stress, Anxiety, and Depression · NA · not yet recruiting
- NCT06262646 — Video-conferencing FACT for Young Children With Special Needs · NA · completed
- NCT05584059 — Pai.ACT Programme for Parents of Children With Special Healthcare Needs - Phase I · NA · recruiting
Other recruiting trials for Neurodevelopmental Disorders
Currently open trials in the same condition.
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT06915480 — Reducing Missed Appointments · Phase 3 · recruiting
- NCT06807203 — Motor-voice Assessment in Infants (MAMI) · recruiting
- NCT05815095 — Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services · recruiting
- NCT06974136 — tES Modalities for the Treatment of ADHD · NA · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05803252 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 5 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05803252.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing